These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
328 related items for PubMed ID: 7672492
1. Peripheral and hepatic insulin sensitivity in subjects with impaired glucose tolerance. Berrish TS, Hetherington CS, Alberti KG, Walker M. Diabetologia; 1995 Jun; 38(6):699-704. PubMed ID: 7672492 [Abstract] [Full Text] [Related]
2. GLP-1 does not not acutely affect insulin sensitivity in healthy man. Orskov L, Holst JJ, Møller J, Orskov C, Møller N, Alberti KG, Schmitz O. Diabetologia; 1996 Oct; 39(10):1227-32. PubMed ID: 8897012 [Abstract] [Full Text] [Related]
3. Decreased hepatic glucagon responses in type 1 (insulin-dependent) diabetes mellitus. Orskov L, Alberti KG, Mengel A, Møller N, Pedersen O, Rasmussen O, Seefeldt T, Schmitz O. Diabetologia; 1991 Jul; 34(7):521-6. PubMed ID: 1916058 [Abstract] [Full Text] [Related]
5. Feedback inhibition of insulin and glucagon secretion by insulin is altered in abdominal obesity with normal or impaired glucose tolerance. Cavallo-Perin P, Bruno A, Scaglione L, Gruden G, Cassader M, Pagano G. Acta Diabetol; 1993 Jul; 30(3):154-8. PubMed ID: 8111076 [Abstract] [Full Text] [Related]
6. Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans. Luzi L, DeFronzo RA. Am J Physiol; 1989 Aug; 257(2 Pt 1):E241-6. PubMed ID: 2669517 [Abstract] [Full Text] [Related]
8. Effect of danazol-induced chronic hyperglucagonaemia on glucose tolerance and turnover. Kotzmann H, Linkesch M, Ludvik B, Clodi M, Luger A, Schernthaner G, Prager R, Klauser R. Eur J Clin Invest; 1995 Dec; 25(12):942-7. PubMed ID: 8719935 [Abstract] [Full Text] [Related]
9. Characterisation of beta-cell dysfunction of impaired glucose tolerance: evidence for impairment of incretin-induced insulin secretion. Fritsche A, Stefan N, Hardt E, Häring H, Stumvoll M. Diabetologia; 2000 Jul; 43(7):852-8. PubMed ID: 10952457 [Abstract] [Full Text] [Related]
10. Impaired glucose tolerance (IGT) is associated with reduced insulin-induced suppression of glucagon concentrations. Ahrén B, Larsson H. Diabetologia; 2001 Nov; 44(11):1998-2003. PubMed ID: 11719830 [Abstract] [Full Text] [Related]
17. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics. Baron AD, Schaeffer L, Shragg P, Kolterman OG. Diabetes; 1987 Mar; 36(3):274-83. PubMed ID: 2879757 [Abstract] [Full Text] [Related]
18. Assessment of hepatic insulin action in obese type 2 diabetic patients. Staehr P, Hother-Nielsen O, Levin K, Holst JJ, Beck-Nielsen H. Diabetes; 2001 Jun; 50(6):1363-70. PubMed ID: 11375337 [Abstract] [Full Text] [Related]
20. Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance. Bock G, Dalla Man C, Campioni M, Chittilapilly E, Basu R, Toffolo G, Cobelli C, Rizza R. Diabetes; 2006 Dec; 55(12):3536-49. PubMed ID: 17130502 [Abstract] [Full Text] [Related] Page: [Next] [New Search]